Clinical Trial Center for Functional Foods, Chonbuk National University Hospital
Jeonju, Jeollabuk-do, 560-822, South Korea
NCT Number: NCT01854164
This study was conducted to investigate the effects of daily supplementation of hydrolyzed ginseng extract(HGE) on glycemic status in subjects with impaired fasting glucose(IFG).
Looking for future studies?
Notify Me20 year–70 year
All sexes
Interventional
Not applicable
Jeonju, Jeollabuk-do, 560-822, South Korea
This study was a 8 weeks, randomized, double-blind, placebo-controlled trial. Twenty subjects were randomly divided into HGE or a placebo group. Fasting and postprandial glucose profiles during oral glucose tolerance test (OGTT) were assessed before and after the intervention.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 8 weeks
Changes of fasting and postprandial glucose during OGTT were assessed before(baseline) and after the intervention.
Time frame: 8 weeks
Changes of blood insulin during OGTT were assessed before(baseline) and after the intervention.
Time frame: 8 weeks
Changes of glycated albumin, fructosamine, and lipid profile were assessed before(baseline) and after the intervention
Chonbuk National University Hospital
Other
An 8 Weeks, Randomized, Double-blind, Placebo-controlled Clinical Trial for Anti-diabetic Effects of Hydrolyzed Ginseng Extract
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07686939
Glucose Metabolism Disorders, Glycemic Control
Taizhou, Zhejiang, China
View Trial DetailsNCT05557227
Glucose Metabolism Disorders, Hyperglycemia
Aarhus, Region Midt, Denmark
View Trial DetailsNCT07669389
Diabetes Mellitus, Diabetes Mellitus, Type 2
Chiang Rai, Changwat Chiang Rai, Thailand
View Trial DetailsNCT04001049
Brain Diseases, Brain Ischemia
Madrid, Spain
View Trial Details